Lavigie
ActiveSummary
Lavigie has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.4m and a net result of €341,606. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 33% of 2,952 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Financials · financial year 2025, abbreviated format
In the rankings
#3 company by total assets in Schilde, Health and social work sector#5 company by equity in Schilde, Health and social work sector
2025 annual accounts filed late (5 days) Filed on 5 May 2026, deadline 30 April 2026 (7 months after the close on 30 September 2025, Companies Code art. 3:10). Source: NBB, 2026-00102193.
Equity
€3.4m▲ 11.2%
2024 · €3.1m
Total assets
€9.1m▲ 4.7%
2024 · €8.6m
Net result
€341,606▼ 24.8%
2024 · €454,203
Working capital
€1.6m▲ 35.5%
2024 · €1.2m
Trend over the years
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result has fallen two years in a row; 2025 is 10% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.7m
2025
Net result€0.3m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€9.1m
2025
Equity€3.4m
2025
Debt€5.5m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€1.6m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)3.8%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency37.6%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio5.97
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)0.5
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line2019202020212022202320242025
Operating result€0.3m-€0.3m▲ 7.4%€0.4m▲ 10.1%€0.6m▲ 66.8%€0.9m▲ 48.4%€0.7m▼ 17.8%€0.7m▼ 10.3%
Net result€0.1m-€0.1mwithin the sector's middle half▲ 19.0%€0.2mwithin the sector's middle half▲ 30.6%€0.3mabove the sector's middle half▲ 110%€0.6mabove the sector's middle half▲ 66.9%€0.5mabove the sector's middle half▼ 18.9%€0.3mabove the sector's middle half▼ 24.8%
Equity€1.4m-€1.6mabove the sector's middle half▲ 8.6%€1.7mabove the sector's middle half▲ 10.3%€2.0mabove the sector's middle half▲ 19.6%€2.6mabove the sector's middle half▲ 27.3%€3.1mabove the sector's middle half▲ 17.4%€3.4mabove the sector's middle half▲ 11.2%
Total assets€8.6m-€8.5mabove the sector's middle half▼ 2.0%€8.4mabove the sector's middle half▼ 1.4%€8.2mabove the sector's middle half▼ 1.8%€8.7mabove the sector's middle half▲ 6.2%€8.6mabove the sector's middle half▼ 0.7%€9.1mabove the sector's middle half▲ 4.7%
Debt€7.1m-€6.8m▼ 4.3%€6.5m▼ 4.4%€6.0m▼ 8.0%€6.0m▼ 0.8%€5.4m▼ 8.7%€5.5m▲ 1.2%
Working capital-€0.2m--€0.2mbelow the sector's middle half▲ 19.1%-€0.02mbelow the sector's middle half▲ 88.4%€0.3mwithin the sector's middle half€0.8mwithin the sector's middle half▲ 172%€1.2mabove the sector's middle half▲ 43.1%€1.6mabove the sector's middle half▲ 35.5%
Solvency16.6%-18.3%below the sector's middle half▲ 1.8pp20.5%below the sector's middle half▲ 2.2pp25.0%below the sector's middle half▲ 4.5pp29.9%below the sector's middle half▲ 5.0pp35.4%within the sector's middle half▲ 5.5pp37.6%within the sector's middle half▲ 2.2pp
Current ratio0.82-0.85below the sector's middle half▲ 0.020.98below the sector's middle half▲ 0.131.52within the sector's middle half▲ 0.542.35within the sector's middle half▲ 0.834.15within the sector's middle half▲ 1.815.97within the sector's middle half▲ 1.82
Return on assets (ROA)1.2%-1.4%below the sector's middle half▲ 0.3pp1.9%below the sector's middle half▲ 0.5pp4.1%below the sector's middle half▲ 2.2pp6.4%within the sector's middle half▲ 2.3pp5.3%within the sector's middle half▼ 1.2pp3.8%below the sector's middle half▼ 1.5pp
Staff (FTE)0.6-1.1within the sector's middle half▲ 83.3%1below the sector's middle half▼ 9.1%0.8below the sector's middle half▼ 20.0%0.6below the sector's middle half▼ 25.0%0.5below the sector's middle half▼ 16.7%0.5below the sector's middle half=
above
within
below
the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €9.1m
Fixed assets
€7.1m ▲ 0.5%
Current assets
€2.0m ▲ 23.5%
Equity and liabilities €9.1m
Equity
€3.4m ▲ 11.2%
Provisions
€137,702 =
Debt
€5.5m ▲ 1.2%
Debt's share of the balance-sheet total falls from 63.0% to 60.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€739,841▼
2024 · €851,169
Cash flow
€419,844▼
2024 · €567,689
Debt to equity
1.62▼
2024 · 1.78
ROE
10.0%▼
2024 · 14.8%
Interest coverage
7.31▼
2024 · 7.52
Debt ≤ 1 year
€327,399▼
2024 · €381,316
Debt > 1 year
€5.0m▼
2024 · €5.1m
Income taxes
€226,047▲
2024 · €177,047
Staff costs
€17,772▼
2024 · €48,640
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | €0.06m | €0.05m | €0.04m | €0.05m | €0.02m | ▼ 63.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.2m | €0.2m | €0.2m | €0.1m | €0.1m | €0.1m | €0.08m | ▼ 31.1% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | €0.02m | €0.03m | - | - | - | - |
| Other operating charges640/8 | - | - | €0.01m | €0.03m | €0.02m | €0.04m | €0.05m | ▲ 7.7% |
| Gross operating margin9900 | €0.5m | €0.6m | €0.6m | €0.9m | €1.1m | €0.9m | €0.8m | ▼ 14.7% |
| Operating profit (loss)9901 | €0.3m | €0.3m | €0.4m | €0.6m | €0.9m | €0.7m | €0.7m | ▼ 10.3% |
| Financial income75/76B | - | - | €20 | €0 | €0.004m | €0.007m | €0.007m | ▲ 6.3% |
| Recurring financial income75 | - | - | €20 | €0 | €0.004m | €0.007m | €0.007m | ▲ 6.3% |
| Financial charges65/66B | - | - | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | ▼ 10.7% |
| Recurring financial charges65 | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | ▼ 10.7% |
| Profit (loss) for the period before taxes9903 | €0.2m | €0.2m | €0.2m | €0.5m | €0.8m | €0.6m | €0.6m | ▼ 10.1% |
| Income taxes67/77 | €0.07m | €0.09m | €0.09m | €0.2m | €0.2m | €0.2m | €0.2m | ▲ 27.7% |
| Profit (loss) for the period9904 | €0.1m | €0.1m | €0.2m | €0.3m | €0.6m | €0.5m | €0.3m | ▼ 24.8% |
| Profit (loss) for the period to be appropriated9905 | €0.1m | €0.1m | €0.2m | €0.3m | €0.6m | €0.5m | €0.3m | ▼ 24.8% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €8.6m | €8.5m | €8.4m | €8.2m | €8.7m | €8.6m | €9.1m | ▲ 4.7% |
| Fixed assets21/28 | €7.7m | €7.6m | €7.4m | €7.3m | €7.2m | €7.1m | €7.1m | ▲ 0.5% |
| Intangible fixed assets21 | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Tangible fixed assets22/27 | €2.2m | €2.0m | €1.9m | €1.8m | €1.7m | €1.5m | €1.6m | ▲ 2.1% |
| Land and buildings22 | - | - | €1.8m | €1.7m | €1.6m | €1.5m | €1.5m | ▼ 1.6% |
| Plant, machinery and equipment23 | - | - | €0.004m | €0.001m | - | - | €0.002m | - |
| Furniture and vehicles24 | - | - | €0.05m | €0.04m | €0.04m | €0.04m | €0.09m | ▲ 146% |
| Other tangible fixed assets26 | - | - | €0.02m | €0.02m | €0.1m | €0.02m | €0.02m | ▲ 1.4% |
| Financial fixed assets28 | €5.5m | €5.5m | €5.5m | €5.5m | €5.5m | €5.5m | €5.5m | = |
| Current assets29/58 | €0.9m | €0.9m | €0.9m | €0.9m | €1.5m | €1.6m | €2.0m | ▲ 23.5% |
| Amounts receivable within one year40/41 | - | €0.005m | - | - | €0.02m | €0.03m | €0.4m | ▲ 931% |
| Trade receivables40 | - | - | - | - | €0.02m | €0.03m | €0.03m | ▼ 6.9% |
| Other amounts receivable41 | - | - | - | - | - | - | €0.3m | - |
| Current investments50/53 | - | - | - | - | €0.2m | €0.2m | €0.5m | ▲ 127% |
| Cash at bank and in hand54/58 | €0.8m | €0.7m | €0.8m | €0.6m | €1.0m | €1.1m | €1.1m | ▲ 1.2% |
| Deferred charges and accrued income490/1 | - | - | €0.1m | €0.3m | €0.3m | €0.3m | €0.04m | ▼ 83.0% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €8.6m | €8.5m | €8.4m | €8.2m | €8.7m | €8.6m | €9.1m | ▲ 4.7% |
| Equity10/15 | €1.4m | €1.6m | €1.7m | €2.0m | €2.6m | €3.1m | €3.4m | ▲ 11.2% |
| Contributions10/11 | €0.4m | - | €0.4m | €0.4m | €0.4m | €0.4m | €0.4m | = |
| Reserves13 | €1.0m | €1.1m | €1.3m | €1.6m | €2.2m | €2.6m | €3.0m | ▲ 12.9% |
| Non-distributable reserves130/1 | - | - | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | = |
| Reserves not available under the articles1311 | - | - | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | = |
| Distributable reserves133 | - | - | €1.3m | €1.6m | €2.2m | €2.6m | €3.0m | ▲ 12.9% |
| Provisions and deferred taxes16 | €0.07m | €0.08m | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | = |
| Provisions for liabilities and charges160/5 | - | - | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | = |
| Other liabilities and charges164/5 | - | - | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | = |
| Amounts payable17/49 | €7.1m | €6.8m | €6.5m | €6.0m | €6.0m | €5.4m | €5.5m | ▲ 1.2% |
| Amounts payable after more than one year17 | €5.9m | €5.7m | €5.5m | €5.4m | €5.3m | €5.1m | €5.0m | ▼ 1.3% |
| Financial debts170/4 | - | - | €5.5m | €5.4m | €5.3m | €5.1m | €5.0m | ▼ 1.3% |
| Amounts payable within one year42/48 | €1.1m | €1.1m | €0.9m | €0.6m | €0.6m | €0.4m | €0.3m | ▼ 14.1% |
| Current portion of amounts payable after more than one year42 | - | - | €0.2m | €0.2m | €0.2m | €0.1m | €0.07m | ▼ 50.0% |
| Trade debts44 | €0.2m | €0.2m | €0.3m | €0.2m | €0.1m | €0.08m | €0.09m | ▲ 12.7% |
| Suppliers440/4 | - | - | €0.3m | €0.2m | €0.1m | €0.08m | €0.09m | ▲ 12.7% |
| Taxes, remuneration and social security45 | - | - | €0.03m | €0.07m | €0.09m | €0.04m | €0.06m | ▲ 53.6% |
| Taxes450/3 | - | - | €0.03m | €0.06m | €0.09m | €0.04m | €0.06m | ▲ 53.6% |
| Remuneration and social security454/9 | - | - | €0.007m | €0.008m | €0.005m | - | - | - |
| Other amounts payable47/48 | - | - | €0.5m | €0.1m | €0.3m | €0.1m | €0.1m | ▼ 15.0% |
| Accrued charges and deferred income492/3 | - | - | €0.04m | €0.06m | - | - | €0.2m | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €103,038 | €122,628 | €160,117 | €335,534 | €559,970 | €454,203 | €341,606 | ▼ 24.8% |
| + Depreciation and write-downs630 | €152,526 | €150,277 | €150,369 | €141,726 | €129,006 | €113,486 | €78,238 | ▼ 31.1% |
| Operating cash flow (approximation) | €255,564 | €272,904 | €310,486 | €477,260 | €688,976 | €567,689 | €419,844 | ▼ 26.0% |
| Investment in fixed assets (approximation) | - | -€8,000 | -€22,998 | -€9,312 | -€80,435 | €67,624 | -€111,370 | - |
| Change in cash | - | -€81,559 | €58,066 | -€161,578 | €382,037 | €90,250 | €13,409 | ▼ 85.1% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 24 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-09-2025 | abbreviated format | 05-05-2026 | 2026-00102193 |
| 30-09-2024 | abbreviated format | 30-04-2025 | 2025-00090306 |
| 30-09-2023 | abbreviated format | 15-05-2024 | 2024-00088002 |
| 30-09-2022 | abbreviated format | 14-05-2024 | 2024-00088404 |
| 30-09-2021 | abbreviated format | 02-05-2022 | 2022-20015574 |
| 30-09-2020 | abbreviated format | 30-04-2021 | 2021-12700487 |
| 30-09-2019 | abbreviated format | 28-04-2020 | 2020-11200591 |
| 30-09-2018 | abbreviated format | 20-08-2019 | 2019-48000541 |
| 30-09-2017 | abbreviated format | 16-05-2018 | 2018-13100160 |
| 30-09-2016 | abbreviated format | 18-04-2017 | 2017-09500522 |
Similar companies · same sector, comparable size
M.D.V.Dr.P.Matthys
BE 0865.201.101
Leuven · equity €3,398,295
DOKTER LEFEVERE FILIP
BE 0836.300.148
Gent · equity €3,427,259
DOKTERS MARCHAL - DE VADDER
BE 0879.679.835
Sint-Katelijne-Waver · equity €3,374,264
DR. B. DE CORDIER
BE 0885.935.840
Gent · equity €3,372,461
Dr. Peter Van Oyen
BE 0462.071.376
Brugge · equity €3,363,682
Of the 16,566 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,105. 3,352 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.